US Stock MarketDetailed Quotes

BGLC BioNexus Gene Lab

Watchlist

0.350
+0.119+51.32%

Close Dec 2 16:00 ET

0.313
-0.037-10.46%

Post 20:01 ET

6.29MMarket Cap29.17P/E (TTM)

BioNexus Gene Lab Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-62.29%-1.46M

-2,714.67%-670.54K

70.44%-34.44K

-335.87%-1.3M

-154.94%-261.91K

-391.15%-899.35K

87.84%-23.82K

-207.93%-116.52K

5,923.60%551.82K

-1.30%476.74K

Net income from continuing operations

48.44%-1.35M

176.80%199.1K

-50.23%-103.76K

-638.57%-2.63M

296.51%308.46K

-3,271.00%-2.61M

-86.97%-259.25K

-504.70%-69.07K

-147.36%-355.97K

-275.89%-156.97K

Operating gains losses

-104.87%-59.63K

-80.29%-20K

-73.95%-15.13K

46.78%-61.41K

84.86%-12.52K

-117.15%-29.1K

8.27%-11.09K

-20.28%-8.7K

-423.59%-115.38K

-865.70%-82.65K

Depreciation and amortization

67.55%49.08K

27.83%31.46K

18.97%29.59K

2.85%108.42K

13.81%29.66K

13.38%29.29K

-8.45%24.61K

-6.68%24.87K

-2.58%105.42K

-1.73%26.06K

Other non cash items

-5.62%2.44K

1,148.99%30.39K

52.39%2.71K

13.90%8.88K

-8.36%2.08K

48.73%2.58K

--2.43K

--1.78K

--7.79K

--2.27K

Change In working capital

-100.70%-744

-1,312.91%-326.33K

113.98%3.92K

-85.84%117.98K

-98.32%12.44K

-65.22%106.64K

119.88%26.91K

64.14%-28.01K

196.65%833.39K

104.40%740.15K

-Change in receivables

-32.91%139.92K

1,192.19%153.23K

-131.16%-105.67K

9.71%606.16K

7.83%72.59K

871.71%208.55K

-108.70%-14.03K

12.12%339.05K

-14.24%552.51K

-91.07%67.32K

-Change in inventory

-719.65%-356.07K

116.51%43.95K

-22.20%60.82K

-129.48%-160.39K

-125.30%-29.89K

-86.20%57.46K

-294.68%-266.14K

161.56%78.17K

257.37%544.11K

445.06%118.14K

-Change in payables and accrued expense

179.13%200.59K

-259.54%-513.65K

112.75%55.23K

-218.55%-381.29K

-102.57%-16.68K

-89.55%-253.51K

175.39%321.95K

-107.57%-433.06K

89.86%-119.7K

265.29%649.74K

-Change in other current liabilities

-102.23%-2.08K

-53.69%-10.23K

-175.79%-12.04K

160.48%76.62K

95.10%-5.37K

1,696.16%93.01K

-7.74%-6.65K

12.80%-4.37K

-528.12%-126.69K

-2,431.20%-109.68K

-Change in other working capital

1,403.29%16.9K

104.36%359

171.50%5.58K

-37.20%-23.12K

-156.19%-8.22K

-86.77%1.12K

-7,589.72%-8.23K

80.43%-7.8K

-142.16%-16.85K

--14.63K

Cash from discontinued investing activities

Operating cash flow

-62.29%-1.46M

-2,714.67%-670.54K

70.44%-34.44K

-335.87%-1.3M

-154.94%-261.91K

-391.15%-899.35K

87.84%-23.82K

-207.93%-116.52K

5,923.60%551.82K

-1.30%476.74K

Investing cash flow

Cash flow from continuing investing activities

49.23%-183.12K

2,816.22%83.06K

576.62%24.1K

15.08%-382.58K

72.44%-13.75K

-2,064.65%-360.71K

98.62%-3.06K

97.44%-5.06K

8.17%-450.5K

34.59%-49.9K

Net PPE purchase and sale

-48.65%-199.19K

87.23%-1.83K

-21,414.71%-21.95K

-175.79%-149.4K

94.50%-937

-3,561.28%-134K

-1,010.29%-14.36K

99.68%-102

-1,613.19%-54.17K

-1,231.27%-17.03K

Net investment purchase and sale

90.49%-24.34K

-2,172.77%-4.19K

371.85%37.1K

42.43%-294.59K

77.73%-25.33K

-3,851.44%-255.81K

100.09%202

92.07%-13.65K

-0.44%-511.71K

-36.09%-113.73K

Net other investing changes

--1.59K

----

Cash from discontinued investing activities

Investing cash flow

49.23%-183.12K

2,816.22%83.06K

576.62%24.1K

15.08%-382.58K

72.44%-13.75K

-2,064.65%-360.71K

98.62%-3.06K

97.44%-5.06K

8.17%-450.5K

34.59%-49.9K

Financing cash flow

Cash flow from continuing financing activities

-103.47%-199.41K

7,234.40%173.58K

1,461.38%24.22K

5,219.80%5.75M

589.05%11.12K

331,172.47%5.75M

-2.43K

-1.78K

483.28%108.17K

54.16%-2.27K

Net issuance payments of debt

----

--0

----

-29.41%-34.04K

--0

Cash dividends paid

--0

Net other financing activities

---196.98K

--175.41K

--26.93K

3,742.13%5.76M

----

7,912.50%150K

----

Cash from discontinued financing activities

Financing cash flow

-103.47%-199.41K

7,234.40%173.58K

1,461.38%24.22K

5,219.80%5.75M

589.05%11.12K

331,172.47%5.75M

---2.43K

---1.78K

483.28%108.17K

54.16%-2.27K

Net cash flow

Beginning cash position

207.85%5.41M

195.57%5.83M

179.84%5.93M

-0.24%2.12M

320.37%6.15M

31.21%1.76M

6.99%1.97M

-0.24%2.12M

-23.81%2.12M

-14.00%1.46M

Current changes in cash

-141.05%-1.84M

-1,311.95%-413.9K

111.25%13.88K

1,842.87%4.07M

-162.31%-264.55K

1,278.54%4.49M

90.41%-29.31K

47.50%-123.35K

141.11%209.49K

5.68%424.56K

Effect of exchange rate changes

670.01%565.22K

97.71%-4.25K

-397.91%-111.03K

-21.04%-259.68K

-79.75%47K

51.29%-99.16K

6.63%-185.22K

50.03%-22.3K

-39.19%-214.55K

966.13%232.03K

End cash Position

-32.69%4.14M

207.85%5.41M

195.57%5.83M

179.84%5.93M

320.37%6.15M

31.21%1.76M

6.99%1.97M

-0.24%2.12M

Free cash flow

-60.52%-1.66M

-1,661.11%-672.37K

51.65%-56.39K

-391.57%-1.45M

-157.18%-262.85K

-438.55%-1.03M

80.65%-38.18K

-66.53%-116.62K

8,195.57%497.65K

-4.57%459.71K

Currency Unit

USD

Audit Opinions

Unqualified Opinion

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-62.29%-1.46M	-2,714.67%-670.54K	70.44%-34.44K	-335.87%-1.3M	-154.94%-261.91K	-391.15%-899.35K	87.84%-23.82K	-207.93%-116.52K	5,923.60%551.82K	-1.30%476.74K
Net income from continuing operations	48.44%-1.35M	176.80%199.1K	-50.23%-103.76K	-638.57%-2.63M	296.51%308.46K	-3,271.00%-2.61M	-86.97%-259.25K	-504.70%-69.07K	-147.36%-355.97K	-275.89%-156.97K
Operating gains losses	-104.87%-59.63K	-80.29%-20K	-73.95%-15.13K	46.78%-61.41K	84.86%-12.52K	-117.15%-29.1K	8.27%-11.09K	-20.28%-8.7K	-423.59%-115.38K	-865.70%-82.65K
Depreciation and amortization	67.55%49.08K	27.83%31.46K	18.97%29.59K	2.85%108.42K	13.81%29.66K	13.38%29.29K	-8.45%24.61K	-6.68%24.87K	-2.58%105.42K	-1.73%26.06K
Other non cash items	-5.62%2.44K	1,148.99%30.39K	52.39%2.71K	13.90%8.88K	-8.36%2.08K	48.73%2.58K	--2.43K	--1.78K	--7.79K	--2.27K
Change In working capital	-100.70%-744	-1,312.91%-326.33K	113.98%3.92K	-85.84%117.98K	-98.32%12.44K	-65.22%106.64K	119.88%26.91K	64.14%-28.01K	196.65%833.39K	104.40%740.15K
-Change in receivables	-32.91%139.92K	1,192.19%153.23K	-131.16%-105.67K	9.71%606.16K	7.83%72.59K	871.71%208.55K	-108.70%-14.03K	12.12%339.05K	-14.24%552.51K	-91.07%67.32K
-Change in inventory	-719.65%-356.07K	116.51%43.95K	-22.20%60.82K	-129.48%-160.39K	-125.30%-29.89K	-86.20%57.46K	-294.68%-266.14K	161.56%78.17K	257.37%544.11K	445.06%118.14K
-Change in payables and accrued expense	179.13%200.59K	-259.54%-513.65K	112.75%55.23K	-218.55%-381.29K	-102.57%-16.68K	-89.55%-253.51K	175.39%321.95K	-107.57%-433.06K	89.86%-119.7K	265.29%649.74K
-Change in other current liabilities	-102.23%-2.08K	-53.69%-10.23K	-175.79%-12.04K	160.48%76.62K	95.10%-5.37K	1,696.16%93.01K	-7.74%-6.65K	12.80%-4.37K	-528.12%-126.69K	-2,431.20%-109.68K
-Change in other working capital	1,403.29%16.9K	104.36%359	171.50%5.58K	-37.20%-23.12K	-156.19%-8.22K	-86.77%1.12K	-7,589.72%-8.23K	80.43%-7.8K	-142.16%-16.85K	--14.63K
Cash from discontinued investing activities
Operating cash flow	-62.29%-1.46M	-2,714.67%-670.54K	70.44%-34.44K	-335.87%-1.3M	-154.94%-261.91K	-391.15%-899.35K	87.84%-23.82K	-207.93%-116.52K	5,923.60%551.82K	-1.30%476.74K
Investing cash flow
Cash flow from continuing investing activities	49.23%-183.12K	2,816.22%83.06K	576.62%24.1K	15.08%-382.58K	72.44%-13.75K	-2,064.65%-360.71K	98.62%-3.06K	97.44%-5.06K	8.17%-450.5K	34.59%-49.9K
Net PPE purchase and sale	-48.65%-199.19K	87.23%-1.83K	-21,414.71%-21.95K	-175.79%-149.4K	94.50%-937	-3,561.28%-134K	-1,010.29%-14.36K	99.68%-102	-1,613.19%-54.17K	-1,231.27%-17.03K
Net investment purchase and sale	90.49%-24.34K	-2,172.77%-4.19K	371.85%37.1K	42.43%-294.59K	77.73%-25.33K	-3,851.44%-255.81K	100.09%202	92.07%-13.65K	-0.44%-511.71K	-36.09%-113.73K
Net other investing changes	--1.59K	----	----	----	----	----	----	----	----	----
Cash from discontinued investing activities
Investing cash flow	49.23%-183.12K	2,816.22%83.06K	576.62%24.1K	15.08%-382.58K	72.44%-13.75K	-2,064.65%-360.71K	98.62%-3.06K	97.44%-5.06K	8.17%-450.5K	34.59%-49.9K
Financing cash flow
Cash flow from continuing financing activities	-103.47%-199.41K	7,234.40%173.58K	1,461.38%24.22K	5,219.80%5.75M	589.05%11.12K	331,172.47%5.75M	-2.43K	-1.78K	483.28%108.17K	54.16%-2.27K
Net issuance payments of debt	----	----	----	--0	----	----	----	----	-29.41%-34.04K	--0
Cash dividends paid	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Net other financing activities	---196.98K	--175.41K	--26.93K	3,742.13%5.76M	----	----	----	----	7,912.50%150K	----
Cash from discontinued financing activities
Financing cash flow	-103.47%-199.41K	7,234.40%173.58K	1,461.38%24.22K	5,219.80%5.75M	589.05%11.12K	331,172.47%5.75M	---2.43K	---1.78K	483.28%108.17K	54.16%-2.27K
Net cash flow
Beginning cash position	207.85%5.41M	195.57%5.83M	179.84%5.93M	-0.24%2.12M	320.37%6.15M	31.21%1.76M	6.99%1.97M	-0.24%2.12M	-23.81%2.12M	-14.00%1.46M
Current changes in cash	-141.05%-1.84M	-1,311.95%-413.9K	111.25%13.88K	1,842.87%4.07M	-162.31%-264.55K	1,278.54%4.49M	90.41%-29.31K	47.50%-123.35K	141.11%209.49K	5.68%424.56K
Effect of exchange rate changes	670.01%565.22K	97.71%-4.25K	-397.91%-111.03K	-21.04%-259.68K	-79.75%47K	51.29%-99.16K	6.63%-185.22K	50.03%-22.3K	-39.19%-214.55K	966.13%232.03K
End cash Position	-32.69%4.14M	207.85%5.41M	195.57%5.83M	179.84%5.93M	179.84%5.93M	320.37%6.15M	31.21%1.76M	6.99%1.97M	-0.24%2.12M	-0.24%2.12M
Free cash flow	-60.52%-1.66M	-1,661.11%-672.37K	51.65%-56.39K	-391.57%-1.45M	-157.18%-262.85K	-438.55%-1.03M	80.65%-38.18K	-66.53%-116.62K	8,195.57%497.65K	-4.57%459.71K
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data